-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_appendixes.pdf
October 06, 2006 - Vol-
Death*
Dr Vol-
CABG* Notes
Primary Studies: National
Kimmel S et
al.248
Society for Cardiac … Clinical Databases: National
Peterson E et
al.210
Society of Thoracic Surgeons
National Cardiac … Pts=patients; Hosp=hospital; vol=volume; Dr=physician; RA= Risk adjusted; AE= Adverse events; CSRS=cardiac … Clinical Databases CABG: National
Peterson E et
al.210
Society of Thoracic
Surgeons National
Cardiac … ischemia
ο Other (Specify _______)
Components of Primary Endpoint (N= ) ο Total Mortality
ο Cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol.pdf
July 09, 2024 - has also been given to other
common co-occurring conditions such as hip dysplasia, early menopause, cardiac … syndrome" or "trisomy 21").mp.
2 atherosclerosis/ or cardiac output, high/ or cardiac output, low/
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol-amendment.pdf
February 05, 2025 - has also been given to other
common co-occurring conditions such as hip dysplasia, early menopause, cardiac … syndrome" or "trisomy 21").mp.
2 atherosclerosis/ or cardiac output, high/ or cardiac output, low/
-
effectivehealthcare.ahrq.gov/health-topics/pacemakers-and-implantable-defibrillators
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
June 01, 2013 - dissuade a physician from
prescribing it for prophylaxis in patients with COPD include hearing loss and cardiac … dissuade a physician from prescribing it for
prophylaxis in COPD patients include hearing loss and cardiac … Some experts
stated risk of hearing loss, cardiac arrhythmias, and antibiotic resistance are factors
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
March 01, 2009 - Collection
Baseline Data
Baseline demographic, medical history, physical examination and initial cardiac … contemporary patients receiving percutaneous coronary
intervention, the long-term risk for death and major cardiac … Acknowledgments
We acknowledge the commitment of faculty and staff of the cardiac
catheterization
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
March 17, 2020 - obesity, diabetes prevention, hypertension, sleep apnea, coronary artery disease,
heart failure, cardiac … ti OR thrombos*:ti OR calcif*:ti))
21 Heart Failure 'heart failure'/exp OR (((heart OR cardio* OR cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb-disposition.pdf
March 10, 2010 - Results Pg 20, line 52- Why didn’t you think it reasonable to pool
cardiovascular mortality and cardiac … which included death from vascular
causes such as stroke) was an inherently different endpoint than cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/phenylketonuria_research-protocol.pdf
March 29, 2011 - affecting
outcomes in their infants, including prevention of neurological impairment,
microcephaly, and cardiac … affecting outcomes in their
infants, including prevention of neurological impairment, microcephaly, and cardiac … Prevention of cardiac defects
3. Normal growth
4. … Prevention of cardiac defects
3. Normal growth
4.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
October 08, 2014 - o include GFR threshold and how measured
§ New onset diabetes after transplant
§ Major adverse cardiac … an d timing var iation s
KQ3
Adverse events:
• Nephrotoxicity
• New onset diabetes
• Major cardiac … living (related or non-related) or
deceased donor renal transplant (brain dead donors, donors after cardiac … type (living donor or deceased donor; for deceased donors: expanded criteria donors,
donation after cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
January 01, 2024 - app-based clinical decision support for atrial fibrillation management.20,23-25
Remote monitoring of cardiac … or software) for
anticoagulation
monitoring
Moderate
CCT = controlled clinical trial; CRT-D = cardiac … resynchronization therapy defibrillator; ICD = implantable cardiac defibrillator;
PM = pacemaker; PSP … 0.80)
AF = atrial fibrillation; CCT = controlled clinical trial; CI = confidence interval; CRT-D = cardiac … resynchronization therapy defibrillator; HR = hazard ratio; ICD = implantable
cardiac defibrillator
-
effectivehealthcare.ahrq.gov/products/atherosclerosis-plaque/technical-brief
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
June 04, 2010 - ketoacidosis
• Neuroleptic malignant syndrome
• Seizures
• Tardive dyskinesia
• Cardiomyopathies
• Cardiac … diabetic ketoacidosis, neuroleptic malignant syndrome, seizures,
tardive dyskinesia, cardiomyopathies and cardiac … agranulocytosis
2. seizures
3. myocarditis
4. cardiovascular and respiratory effects,
(respiratory and/or cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdf
June 01, 2018 - enrollment
o Adverse effects of intervention(s)
Sedation
Weight gain
Changes in appetite
Cardiac … sitter use; hospice enrollment)
o Adverse effects (sedation;
weight gain; changes in
appetite; cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_2-user-guide-to-ocer_130129.pdf
January 01, 2011 - The investigators
compared venlafaxine and other antidepressants
and risk of sudden cardiac death or … Use of
venlafaxine compared with other antidepressants
and the risk of sudden cardiac death or near … Does cardiac transplantation
prolong life? A reassessment. Ann Intern Med.
1972;76(5):815-7.
40.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
January 01, 2022 - treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 (95% CI 0.47 to 0.77)
Cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
January 01, 2007 - The renin system is an
important mediator of blood volume, arterial pressure, and cardiac and vascular … hormone, leading to fluid retention; stimulates
thirst; promotes adrenergic function; and increases cardiac … hormone, leading to fluid retention; stimulates thirst; promotes adrenergic function; and
increases cardiac … Comparative effects of chronic ACE inhibition and
AT1 receptor blocked losartan on cardiac
hypertrophy … term effects of losartan and enalapril, alone or with
a diuretic, on ambulatory blood pressure and cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
June 01, 2014 - Adverse events
associated with azithromycin included hearing loss and cardiac arrhythmias and concerns … dissuade a physician
from prescribing it for prophylaxis in COPD patients include hearing loss and cardiac … These caveats—risks of hearing loss, cardiac arrhythmias, and
antibiotic resistance—are factors that
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
January 01, 2006 - Less is known about COX-3,
which is found in the cerebral cortex and cardiac tissue
and appears to be … found rofecoxib
associated with increased risks of arrhythmia
(primarily ventricular fibrillation, cardiac … arrest, or
sudden cardiac death) and renal dysfunction
(peripheral edema, hypertension, or renal
dysfunction
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
September 13, 2013 - studies:
Placebo, nonfortified/supplemented food
• Outcomes
o CVD clinical outcomes
Cardiac … These comprise the following clinical and related intermediary outcomes:
• CVD clinical outcomes (cardiac